Me too and thanks. I looked the study up on clinicaltrials.gov a long time ago, but I guess it didn't register.
My biggest concern is the performance of Aldox following dox. Could 1st line dox impair the efficacy of 2nd line Aldox?
Why your persistent passionate bashing? Even if you're right, nobody posts like that without a vested interest in the outcome.
It just seems odd for someone new to just pop in here and suddenly start over-posting about some obscure rule. Judging by your passion, it would seem you have a vested interest in your argument.
I believe it's Scott Patterson who just posted for the first time in almost a year, that he still holds his position, and is about to see his wealth increase exponentially this year.
The last time there was this much fear in this stock, it bounced back from below 2 to over 3.
A takeover would fall under the "change in control" clause.
I didn't glean anything sinister from the 8-K, but it is a scary headline per se.
Buy when others are afraid.